Kinea Ventures

Kinea Ventures is the venture arm of Kinea Investimentos, a major Brazilian asset manager affiliated with Itau Unibanco, deploying $1M-$5M cheques at Series A and Series B into technology businesses serving enterprises, including Health IT and digital health platforms. The firm benefits from access to Itau’s enterprise customer base and Brazil’s largest banking distribution network, which can be a meaningful go-to-market lever for B2B health software founders. For founders, Kinea is best understood as a CVC-flavoured Series A and B partner that combines institutional venture rigor with strategic corporate access. The right founder is a Brazilian operator building enterprise health software, RCM, EHR, payer-facing analytics, or care coordination platforms with audited revenue, multi-year customer contracts, and ambitions to scale across Brazil and selectively into the rest of LatAm. Founders running consumer wellness, asset-heavy clinic models, or pre-revenue plays should not approach. Entry path is through a Kinea portfolio CEO, sell-side bankers (BTG, Itau BBA), or warm introductions from Itau-affiliated executives. In the pitch, lead with ARR, gross retention, sales cycle economics, governance maturity, and a credible Series B plan that contemplates international leads (Tiger, Riverwood, Softbank LatAm) where relevant. Caveats: as a regulated financial group affiliate, Kinea’s processes are institutional and term sheets may include strategic provisions tied to Itau’s enterprise relationship. The fund is not branded as AI-first, so AI-heavy founders should expect commercial rather than deep technical diligence. Brazil’s macro and currency volatility, plus payer concentration in SUS and a consolidated private insurance market, are structural realities worth pricing into the conversation early. Confirm reserves and follow-on cadence explicitly during diligence.